Saturday, October 3, 2026

USD/EUR Bearish By 2% In The Last 21 Sessions

USD/EUR Bearish By 2% In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 2.59% for the last 21 sessions. At 23:09 EST on Thursday, 6 April, USD/EUR (USDEUR) is $0.92.

USD/EUR's yearly highs and lows, it's 0.937% up from its 52-week low and 12.669% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.08%, a negative 0.12%, and a positive 0.46%, respectively.

USD/EUR's highest amplitude of average volatility was 0.55% (last week), 0.52% (last month), and 0.46% (last quarter), respectively.

News about

  • Eur/usd price analysis: h&s confirmation favors euro bears around 1.0890. According to FXStreet on Thursday, 6 April, "It's worth noting, however, that a light calendar and receding strength of the bearish MACD signals seem to challenge the EUR/USD sellers of late.", "Alternatively, the 200-Hour Moving Average (HMA) precedes a two-week-long ascending trend line to restrict short-term EUR/USD downside around 1.0865 and 1.0830 in that order."
  • Eur/usd retreats to 1.0900 despite weaker-than-expected US data. According to FXStreet on Wednesday, 5 April, "The EUR/USD corrected to the 1.0900 zone after the beginning of the American session and despite weaker-than-expected US economic data. "
  • Eur/usd forex signal: cup and handle pattern is forming - 06 April 2023. According to DailyForex on Thursday, 6 April, "The main catalyst for the EUR/USD pullback was a statement by Cleveland Fed's Loretta Mester. ", "The 4H chart shows that the EUR/USD pair has been in a bullish trend in the past few days. "
  • Eur/usd forecast: euro faces challenges, but shows strength - 05 April 2023. According to DailyForex on Wednesday, 5 April, "However, the EUR/USD market is currently in an extreme high and it remains to be seen whether the gains will be sustained. "
  • Eur/usd ignores dovish shift in fed bets to approach 1.0860 support amid recession woes. According to FXStreet on Thursday, 6 April, "However, downbeat US data and comparatively hawkish bets on the European Central Bank (ECB) than the US Federal Reserve (Fed) seem to put a floor under the EUR/USD prices.", "Looking forward, EUR/USD traders will be interested in more clues for Friday's all-important Nonfarm Payrolls (NFP)."

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com